id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2646955,7fcfa42e-7a57-4e0e-bf45-d7c0f7791c80,2A,"TARPLIN, DOWNS & YOUNG, LLC",304736,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2021,second_quarter,HCR,"H.R. 1319, American Rescue Plan of 2021 implementation
S. 1260, U.S. Innovation and Competition Act of 2021

no specific bills, health care reform, Biosimilars, FDA policies, Innovation, 340B, comparative effectiveness research, non-interference, opioids, pandemic preparedness","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",80000,,0,0,2021-07-19T14:05:28.917000-04:00